BACKGROUND: Kv1.5 (Potassium voltage-gated channel subfamily A member 5) has been regarded as a promising target of interventions for atrial fibrillation (AF). SNX17 (sorting nexin 17), a member of the SNXs (sorting nexin family), regulates the intracellular trafficking of membrane proteins through its FERM (four-point-one, ezrin, radixin, moesin) domain. However, whether SNX17 regulates the trafficking process of Kv1.5 remains unknown.
A trial fibrillation (AF) is a common cardiac disease in clinical practice with significant population morbidity. 1 Currently, drug therapy is still widely used for AF intervention 2 because of its noninvasiveness and lower cost compared with ablation therapy. Unfortunately, most of these drugs have the potential to cause new or more serious arrhythmias. 1, 3 New targets for arrhythmic drugs are urgently needed. 4 Given the atrial-specific expressions and alterations in human AF, Kv1.5 (potassium voltage-gated channel subfamily a member 5) is known to be a promising target. 4 Several selective I Kur blockers have been proven effective in AF intervention. 2, 5, 6 However, knowledge about the intracellular biological regulation of Kv1.5 is still limited.
7 SNX17 (sorting nexin 17) is an adaptor molecule that has been reported to regulate the trafficking of multiple plasma membrane proteins, such as P-selectin, LRP (low-density lipoprotein receptorrelated protein), and integrin, by controlling their endocytic trafficking through the specific cargo-binding site. [8] [9] [10] [11] However, the role of SNX17 in Kv1.5 regulation is unclear. Here, we report that SNX17 mediates atrial electrophysiology and susceptibility to AF by regulating endocytic sorting of the Kv1.5 channel through the FERM (four-point-one, ezrin, radixin, moesin) domain.
METHODS
This study was reviewed and approved by the Institutional Review Board of Shanghai East Hospital, Tongji University. The data, analytic methods, and study materials have been made available to other researchers for purposes of reproducing the results or replicating the procedure. The authors declare that all supporting data are available within the article and in the Data Supplement.
Generation of SNX17 Knockout Rats
A CRISPR/Cas9-based genome-editing technique was adopted to produce SNX17 knockout Sprague-Dawley rats by targeting exons 2 and 3 of the SNX17 gene. We used the CRISPR design tool (http://crispr.mit.edu/) to design the single-guide RNA, which guides Cas9 DNA endonuclease to cleave the SNX17 gene and create a double-strand break, disrupting the expression of SNX17 by a frameshift mutation. The offspring were genotyped using polymerase chain reaction from genomic DNA. The following primers were used: 5'-TTTTGACTGGGTCTTCTGT-3' (forward) and 5'-GATCAGTTTCCACGCTAGAT-3' (reverse) to detect the SNX17 knockout allele and 5'-AGCCGTGATTAAAGGGTA-3' (reverse) to detect the wild-type (WT) allele. To confirm the efficiency of SNX17 deletion, Western blotting was used to detect the protein expression of SNX17 in WT and heterozygous (SNX17 heterozygous knockout [SNX17-HT]) rats. Considering the higher incidence of AF in man, 12 male rats (10-12 weeks) were used in this study. The number of rats used is based on experience and pretest. All rats used in the experiments were randomized and assigned a coded number to which the investigator carrying out the experiments was blinded. All animal protocols were approved by the Animal Care and Use Committee at Tongji University School of Medicine and conducted according to the National Institutes of Health Guidelines for Care and Use of Animals in Research (National Institutes of Health Publication No. 85-23, revised 1996).
Adult Rat Atrial Myocyte Isolation
Adult rat cardiomyocytes were freshly isolated with a standard Langendorff-isolation procedure. 13 Briefly, rats (10 weeks of age) were injected (intraperitoneally) with heparin (1000 IU per kg body weight) and anesthetized with 5% isoflurane. Hearts were excised quickly and Langendorff perfused from the aorta with Ca 2+ -free Tyrode buffer and digestion buffer. Additional details are provided in the Data Supplement.
Whole-Cell Patch Clamping
Whole-cell patch clamping was applied for action potential (AP) and current recoding as previously described. 13 Briefly, borosilicate glass microelectrodes with tip resistances of 2 to 5 MΩ, when filled with pipette solution, were used. The data were collected in the current clamp mode or the voltage clamp mode through an EPC-10 amplifier (HEKA, Germany) with standard patch-clamp techniques at room temperature (22-24°C). For AP recording, 2 minutes after achieving a whole-cell patch-clamp configuration, the AP was elicited by a stimulus at 500 to 700 nA for 1 ms. Currents were recorded 2 min after achieving a whole-cell configuration. The series resistance and capacitance were compensated, and leak currents were subtracted. All individual currents were normalized to membrane capacitance, expressed as the current density (pA/pF). The relevant analysis software included Patchmaster 2.42, Clampfit 10.7 and Igor pro 6.1.
Optical Mapping
The cardiac optical mapping procedure was similar to the previously described procedure.
14 Briefly, atrial preparations were immobilized using blebbistatin (15 μmol/L; Tocris Bioscience) and superfused with the voltage-sensitive dye
WHAT IS KNOWN?
• Atrial fibrillation is one of the most common cardiac arrhythmias. • Kv1.5 (potassium voltage-gated channel subfamily a member 5), the channel protein for the IKur current, is specifically expressed in the mammalian atrium.
WHAT THE STUDY ADDS?
• SNX17 (sorting nexin 17) mediates atrial electrophysiology and susceptibility to atrial fibrillation by selectively regulating endocytic sorting of the Kv1.5 channel through the FERM (four-point-one, ezrin, radixin, moesin) domain.
• SNX17 is a potential target for atrial fibrillation intervention.
RH237 (1 μmol/L; Molecular Probes). Changes in fluorescence were collected at a speed of 500 frames/s in a 2×2 cm 2 field using a MiCam ULTIMA imaging system (SciMedia, CA). Additional details are provided in the Data Supplement.
AF Induction
AF induction in a rat model was based on a previously described study. 15 In brief, for the AF model in isolated hearts, the Langendorff perfusion system and ECG recording system were established following the previous protocol. 16 A 1.8F catheter (Millar Instruments, TX) was inserted to pace the right atrium. When a stable ECG appeared, AF was induced by a burst stimulation (10 Hz lasting 1000 ms). AF was considered inducible if the burst stimulus produced a period of irregular atrial electrograms (>800 beats per minute) with irregular ventricular response and lasted for at least 1000 ms. 17 In vivo electrophysiology in rats was conducted as previously described. 15 The rats were anesthetized using 1.5% isoflurane. A catheter was inserted through the jugular vein to pace the right atrium. Right atrial pacing was performed using 1-ms current pulses delivered by an external stimulator (STG-3008, Multi-Channel Systems, Germany). The atrial effective refractory period was determined by applying a series of atrial-pacing trains at a fixed basic cycle length of 140 ms (S1) with an S2 premature stimulus. To assess AF inducibility, S1-S2-S3 premature stimuli were applied. Additional details are provided in the Data Supplement.
HEK293 Cell Line Culture and Transfection
HEK293 (human embryonic kidney 293) cells were cultured in DMEM medium (Gibco) containing 10% FBS (Gibco), 100 IU/ mL penicillin and 100 μg/mL streptomycin at 37°C in 5% CO 2 . After the cells reached 70% confluence, plasmids expressing truncated mutants of SNX17 (full-length SNX17/∆PX [phox-homology] domain/∆FERM domain/∆C-term domain) fused with a GFP (green fluorescent protein) tag and KCNA5 fused to an RFP (red fluorescent protein) tag were cotransfected with Lipofectamine 3000 (Invitrogen) according to the manufacturer`s protocol. To silence endogenous SNX17 expression in HEK293 cells, which constitutively express KCNA5 (potassium voltage-gated channel subfamily A member 5, or Kv1.5), siRNA (small interfering RNA) against SNX17 and negative control were transfected using Lipofectamine RNAiMAX (Invitrogen). Additional details on plasmids and siRNAs are provided in the Data Supplement.
Biotin-Labeled Surface Cellular Protein Isolation
Biotin-labeled surface cellular protein isolation was performed as described previously. 18 Briefly, cells were incubated with 1 mg/mL sulfo-NHS-LC-Biotin (Pierce) for 30 minutes at 4°C. Unreacted biotin was quenched by a quenching solution containing 100 mmol/L glycine in PBS. The cells were subsequently lysed in radioimmunoprecipitation assay buffer (150 mmol/L NaCl, 50 mmol/L Tris-HCl, pH 7.4, 1% sodium deoxycholate, 1% NP-40, 1 mmol/L phenylmethylsulfonyl fluoride, and 1 mmol/L EDTA). The lysates containing biotinylated proteins were incubated with prewashed streptavidin-agarose beads (Pierce) at 4°C overnight. After being washed 3×, the biotin-bound surface proteins were eluted with loading buffer for Western blotting.
Western Blotting
Briefly, cell lysates or atrial homogenates were used to measure the protein expression of SNX17, Kv1.5, Cav1.2 (L-type calcium channel 1.2), Nav1.5 (voltage-gated sodium channel 1.5), Kv4.2, Kv4.3, KChIP2 (potassium channel interacting protein 2), and Kir2.1 (inward-rectifier potassium ion channel 2.1). Na/K-ATPase, Pan-Cadherin, and GAPDH were used as loading control for membrane and total protein, respectively. Additional details are provided in the Data Supplement.
Immunostaining
Cells were prepared and imaged according to previously published methods. 19 Atrial myocytes were imaged by confocal microscopy (Leica TCS SP8, Germany) using a z-stack model (0.7 µm between each plane). All images were analyzed using LAS AF, ImageJ and IPP 6.0 software. Additional details are provided in the Data Supplement.
Statistics
All data are presented as the mean±SEM. Statistical analyses were performed using Prism Software (GraphPad 5.0). Student unpaired 2-tailed t test was used for direct comparison between the WT and SNX17-HT groups. We performed 1-way ANOVA followed by the Bonferroni multiple comparison test where applicable. AF inducibility was analyzed using the χ 2 test. A P value <0.05 was considered to be statistically significant.
RESULTS

SNX17 Is Preferentially Expressed in the Atrium
We first determined the regional expression of SNX17 at both the mRNA and protein levels. As the results in Figure 1A and 1B show, both the mRNA and protein expression of SNX17 in the atrium are significantly higher than that in the ventricle, indicating that SNX17 might play an important role in the atrium.
SNX17 Selectively Regulates the Membrane Expression of Kv1.5 and I Kur Density in Rat Atrial Myocytes
To explore the role of SNX17 in the atrium, a genetically engineered rat line with SNX17 gene inactivation was generated using CRISPR/Cas9 ( Figure IA and IB in the Data Supplement). The SNX17 heterozygous knockout (SNX17-HT) rats were used for the following experiments because the SNX17 homozygous rats suffered prenatal death. The SNX17-HT rats were viable and appeared normal compared with WT littermates (Fig-Figure 1 . SNX17 (sorting nexin 17) plays an important role in regulating the membrane expression of Kv1.5 (potassium voltage-gated channel subfamily A member 5). A, Expression of the SNX17 mRNA in the atrium and ventricle. *P<0.05, n=3 samples per group. B, Levels of the SNX17 protein in the atrium and ventricle. Upper, Typical Western blotting bands; lower, pooled data from 3 separate experiments. *P<0.05. C, Western blot showing the levels of the SNX17 protein in the atria of wild-type (WT) and SNX17 heterozygous knockout (SNX17-HT) rats. Upper, Representative blots; lower, pooled data. The schematic shows the CRISPR/ Cas9-based genome-editing strategy used to generate SNX17 knockout rats. The red box indicates the deleted exon regions. D and E, Western blots showing the levels of Kv1.5 and other ion channel proteins on the membrane and total proteins from WT or SNX17-HT atria. Upper, Representative blots; bottom, pooled data. *P<0.05, n=5 samples per group. F, Atrial myocytes were fixed and stained for Kv1.5. The stacked images show the full projection of the labeling across all layers in WT and SNX17-HT rats. Upper, Representative image; lower, pooled data for the relative pixel intensity across the cells. *P<0.05. G, Immunofluorescence labeling of endogenous Kv1.5 (red), SNX17 (green), and nuclear staining with DAPI (4′,6-diamidino-2-phenylindole; blue) in isolated intact WT adult rat atrial myocytes. The bottom row indicates the line plot profile of the region of interest from the top row. Arrows indicate overlap in the merged picture. AU indicates fluorescence arbitrary units; Cav1.2, L-type calcium channel 1.2; KChIP2, potassium channel interacting protein 2; Kir2.1, inward-rectifier potassium ion channel 2.1; and Nav1.5, voltage-gated sodium channel 1.5.
ure IIA through IIE in the Data Supplement). Western blotting was used to confirm the efficiency of SNX17 knockdown, showing an obvious reduction of SNX17 protein in the SNX17-HT rat atrium ( Figure 1C) .
Atrial electrophysiology depends on multiple atrial ion channels. 20 Because ion channels mainly function on the plasma membrane, we used Western blotting to test whether SNX17 deficiency changed the surface protein expression of several important ion channels in the atrium. As shown in Figure 1D and 1E, SNX17 deficiency significantly elevated the surface membrane expression of Kv1.5 protein, whereas it did not change either the total protein or the surface protein expression of other atrial channels, such as Nav1.5, Cav1.2, Kv4.3/4.2, Kir2.1, and KChIP2. Kv1.5 localization was further examined by nonpermeabilization staining followed by confocal microscopy. Z-stack projection images demonstrated increased Kv1.5 membrane staining in SNX17-HT atrial myocytes compared with that in the WT group ( Figure 1F ). We also found that endogenous SNX17 and Kv1.5 were partially colocalized in atrial myocytes (Pearson correlation coefficient, Rr=0.81±0.04; Figure 1G ).
To explore whether increased Kv1.5 membrane expression leads to enhanced I Kur , we further compared the electrophysiological properties of atrial myocytes isolated from WT and SNX17-HT rats. In agreement with the Western blotting results, the data in Figure 2A through 2C indicate an increased density of I Kur in SNX17-HT atrial myocytes (17.96±2.13 pA/pF) compared with that of WT atrial myocytes (11.17±1.36 pA/pF). The density of the I to peak current showed no statistically significant differences between WT and SNX17-HT atrial myocytes. Additionally, the inactivation and recovery curve did not change ( Figure 2D and 2E). Because DPO-1 (diphenyl phosphine oxide-1) is a selective blocker of the Kv1.5 channel, we also recorded DPO-1-sensitive outward potassium currents in both groups. The data in Figure 2F and 2G show that SNX17 deficiency enhanced DPO-1-sensitive potassium currents in the SNX17-HT group (2.46±0.36 pA/pF) compared with those in the WT group (1.09±0.21 pA/pF). However, there were no obvious changes in I K1 and I Ca,L current density in SNX17-HT atrial myocytes compared with those in WT atrial myocytes ( Figure IIF through III in the Data Supplement), suggesting that SNX17 deficiency selectively enhances the atrial I Kur current.
SNX17 Deficiency Leads to Atrial AP Duration Shortening
Because the I Kur is thought to play a major role in the cardiac repolarization process, 6 we further investigated whether SNX17 deficiency had an impact on the AP of atrial myocytes. The AP data in Figure 2H through 2J show that the AP duration (APD) at 50% (APD 50 
SNX17 Deficiency Promotes the Inducibility of AF
Considering that shortened atrial APD can promote AF, 1, 3 we evaluated the influence of SNX17 deficiency on atrial effective refractory period and AF inducibility ( Figure 3C through 3F) . A Millar catheter was inserted into the right atrium, and a premature stimulus was used to measure atrial effective refractory period and to initiate AF in WT and SNX17-HT rats. We found that SNX17 deficiency leads to atrial effective refractory period shortening (WT 54.8±1.8 ms, SNX17-HT 48.4±1.9 ms), which could be restored by DPO-1 pretreatment (HT+DPO1 56.8±2.2 ms; Figure 3D) . Figure 3C shows representative surface ECGs and RAEs recorded in WT and HT rats. The programmed stimulus triggered AF in the HT group (5 in 8 rats) but not in the WT group or in the HT group pretreated with DPO-1 (0.5 mg/[kg·min]) for 10 minutes (Figure 3E) . The AF duration was defined as the time that the longest AF episode lasted. The data in Figure 3F show that the average AF duration in the HT group is 4.76±0.98 s. To measure the susceptibility to AF in vitro, intraatrium electric burst pacing (10 Hz for 1 s) was used to provoke the AF in isolated hearts perfused with a Langendorff system. The results showed that sustained AF (lasting longer than 10 s) was induced in 75% of SNX17-HT isolated hearts but not in the WT group ( Figure IIIA and IIIC in the Data Supplement). Another in vitro AF model induced by acetylcholine showed that sustained AF occurred within 20 minutes in 63% of SNX17-HT rats ( Figure IIIB and IIID in the Data Supplement). In contrast, no AF events were observed in WT littermates. AF was not induced in the SNX17-HT group in the presence of DPO-1 both in vivo and in vitro. The above evidence suggests that SNX17 deficiency is tightly linked to the enhanced I Kur and AF occurrence.
SNX17 Facilitates Kv1.5 Trafficking From the Plasma Membrane to Early Endosomes Through the FERM Domain
To explore how SNX17 regulates the surface expression of Kv1.5, we further knocked down SNX17 in an HEK293 cell line expressing Kv1.5. Consistent with the results in atrial myocytes, SNX17 deficiency led to an increase in Kv1.5 surface expression and current density ( Figure 4A  through 4C) . To identify the domain of SNX17 that A, Typical traces of the outward potassium current (I to and I Kur ) in single atrial myocytes from adult wild-type (WT) and SNX17 heterozygous knockout (SNX17-HT) rats. B, Summary data for the peak currents of I to . *P<0.05 compared with WT using ANOVA, n=8 samples per group. C, Summary data for I Kur current density. *P<0.05 compared with WT using ANOVA, n=10 samples per group. D, The inactivation curve of I to . E, The recovery curve of I to . F, Typical traces of DPO-1 (diphenyl phosphine oxide-1; 1 μM) sensitive outward potassium currents in single atrial myocytes from adult WT and HT rats. G. Pooled data for the DPO-1 sensitive current density. *P<0.05 compared with WT using ANOVA, n=9 samples per group. H-J, DPO-1 (1 μM) restored the shortened APD at 50% (APD 50 ) and 90% (APD 90 ) caused by SNX17 deficiency in isolated rat atrial myocytes. H, Representative traces of APs in WT and HT rats treated with or without 1 μM DPO-1. I and J, Pooled data. *P<0.05, n=9 samples per group. The mean values of APD 50 and APD 80 from all pixels on the map. *P<0.05, n=5 samples per group. C, Representative surface ECGs and right atrial electrograms (RAEs) in WT and SNX17-HT rats treated with or without DPO-1. An atrial S1-S2-S3 pacing protocol was used to induce AF in vivo. D, Pooled data for the atrial effective refractory period (AERP) in WT and SNX17-HT rats at a pacing cycle length of 140 ms. E, The incidence of AF induced by the S1-S2-S3 pacing protocol in WT rats, SNX17-HT rats, and SNX17-HT rats treated with DPO-1 in vivo. *P<0.05. F, The duration of the longest inducible AF episode in WT and SNX17-HT rats treated with or without DPO-1. *P<0.05, n=5. regulates Kv1.5 trafficking, we analyzed the colocalization efficiency between Kv1.5 and different truncated mutants of SNX17. As shown in Figure 4D , among the 4 truncated mutants, only the FERM-deleted mutant (SNX17-△FERM) no longer colocalized with Kv1.5, suggesting that the FERM domain is critically responsible for the interaction between Kv1.5 and SNX17. We also performed a coimmunoprecipitation assay between Kv1.5 and SNX17. As shown in Figure 4E , Kv1.5 interacted with the full-length SNX17 and FERM domains but not with the FERM-deleted mutant. Because SNX17 is mainly located in early endosomes and mediates the endocytic trafficking of transmembrane proteins, 21 we assumed that SNX17 mediates the trafficking of Kv1.5 from the plasma membrane to early endosomes. We analyzed the colocalization of Kv1.5 with early endosomes (marked with EEA1 [early endosome antigen 1]) in HEK293 cells transfected with negative control or SNX17-targeted siRNA. As shown in Figure 4F , the colocalization overlap coefficient (Pearson correlation coefficient, Rr) between Kv1.5 and EEA1 decreased in the SNX17-knockdown group compared with that in the control group (from 0.72±0.03 to 0.53±0.03). Internalization to early endosomes is the first step of Kv1.5 trafficking from the plasma membrane. 22, 23 Considering the decreased colocalization of Kv1.5 with the early endosomes in the SNX17-knockdown group, we used Dynasore, a potent inhibitor of dynamin-dependent endocytosis, 24 to block the endocytosis of surface Kv1.5. As shown in Figure 4G , the 1-hour incubation with Dynasore (100 µmol/L) eliminates the difference in surface Kv1.5 expression between the control and SNX17-knockdown groups, suggesting that SNX17 knockdown increased the surface levels of Kv1.5 by interrupting its endocytosis. These results indicate an obvious disruption of Kv1.5 trafficking from the plasma membrane to early endosomes due to SNX17 deficiency.
From the above results, we infer that SNX17 regulates the endocytic trafficking of Kv1.5 from the plasma membrane to early endosomes through the FERM domain. SNX17 deficiency immediately leads to significant plasma membrane retention of Kv1.5 channels, resulting in shortened atrial APD and increased susceptibility to AF.
DISCUSSION
Here, we first report the role of an SNX family member in atrial electrophysiology and AF. First, SNX17 deficiency significantly increases the susceptibility to AF. Second, this susceptibility is related to the significant shortening of the APD caused by increased membrane expression of Kv1.5 and I Kur current. Third, SNX17 defects interrupt the trafficking of Kv1.5 from the surface membrane to early endosomes, whereas the trafficking of other ion channels is not affected. Finally, the FERM domain of SNX17 determines this reuse of Kv1.5. The study reveals a new mechanism of AF.
The subcellular trafficking of the Kv1.5 channel, which includes sorting, recycling, and degradation, 22 is usually performed by GTPase-dependent endosomes. 25 Early endosomes associated with RAB4 (Ras-related protein Rab 4) mediate fast recycling of membrane proteins, whereas recycling endosomes associated with RAB11 coordinate slow recycling. Other studies have reported that microtubules and dynamin contribute to Kv1.5 internalization. 26, 27 Kv1.5 internalization from the cell surface involving early endosomes, followed by later trafficking by the dynein motor along microtubules 23 and the proteasome, is responsible for Kv1.5 protein degradation. 28 Our study shows that SNX17 facilitates trafficking of Kv1.5 to early endosomes from the plasma membrane, which regulates the surface expression and current density of Kv1.5. Abnormal retention of Kv1.5 on the plasma membrane induced by SNX17 deficiency significantly increased the susceptibility to AF.
The sorting nexins are a group of cellular trafficking proteins that are rarely studied in cardiac diseases. Our lab has previously found that SNX13 mediated the heart failure process by degradative sorting of apoptosis repressor with caspase recruitment domain. 23 Recently, Zhao et al 29 provided evidence of the role of SNX17 in acute myocardial infarction-related ventricular arrhythmias. Here, we find for the first time that SNX17 deficiency leads to Kv1.5 retention on the plasma membrane, thus increasing the risk of AF onset.
A previous study has shown that the FERM domain is responsible for the endocytic trafficking and recycling of transmembrane proteins. 21 The FERM domain recruits endosomal membranes and recognizes NPxY (AsnPro-Xaa-Tyr) motif or NxxY (Asn-Xaa-Xaa-Tyr) motif in cargo proteins, such as LRP 30 and KIRT1 (ankyrin repeat-containing protein), 31 for their trafficking. 32 Our study suggests that SNX17 regulates Kv1.5 trafficking through the FERM domain, which is consistent with previous reports. Although NPxY/NxxY peptide sorting motifs have been identified in other ion channels, such as LTCC (L-type calcium channel) and Kv2.1, we did not observe alterations in the expression of surface proteins other than Kv1.5. Owing to study limitations, we were unable to observe direct binding between the FERM domain and peptide sorting motifs, and further research is required to confirm the delicate interaction between SNX17 and Kv1.5. We only presume that the conformation of the FERM domain in SNX17 matches the peptide sorting motifs in Kv1.5.
Based on our data, SNX17 represents a potential target to restore the atrial electrophysiological balance. Actually, the Gene Expression Omnibus dataset (Accession number GSE 41177) shows increased mRNA expression of the SNX17 in the atria of patients with persistent AF 33 ( Figure IV in the Data Supplement). This data reveals the relevance between SNX17 and human AF, though the increased expression of SNX17 in AF patients is opposite to the decrease of SNX17 in our SNX17-deficient rats. As SNX17 facilitates the endocytosis of Kv1.5, either increase or decrease of SNX17 could result in the disruption of I Kur and atrial repolarization, which eventually contributes to the initiation and perpetuation of AF. 34, 35 Nevertheless, further exploration involving SNX17 overexpression animals is required to understand the role of SNX17 in AF thoroughly.
In conclusion, we have revealed a novel role for SNX17 in regulating the endocytic trafficking of Kv1.5, a channel protein expressed in the atria. Stabilizing endocytic trafficking of the Kv1.5 channel by targeting SNX17 may provide a new potential approach for AF intervention. 
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